TY - JOUR
T1 - Direct reprogramming with Sendai virus vectors repaired infarct hearts at the chronic stage
AU - Isomi, Mari
AU - Sadahiro, Taketaro
AU - Fujita, Ryo
AU - Abe, Yuto
AU - Yamada, Yu
AU - Akiyama, Tatsuya
AU - Mizukami, Hiroaki
AU - Shu, Tsugumine
AU - Fukuda, Keiichi
AU - Ieda, Masaki
N1 - Funding Information:
We thank J. Kawaguchi (ID Pharma) and T. Tokusumi (ID Pharma) for their valuable technical support. This work was supported by research grants from the Practical Research Project for Rare/Intractable Diseases ( JP20ek0109305 ), the Research Center Network for Realization of Regenerative Medicine ( JP20bm0704030 ), the Japan Agency for Medical Research and Development , the Japan Society for the Promotion of Science ( 19K22613 , 19K17550 ), and the Takeda Science Foundation .
Publisher Copyright:
© 2021 Elsevier Inc.
PY - 2021/6/30
Y1 - 2021/6/30
N2 - Adult hearts have limited regenerative capacity. Hence, after acute myocardial infarction (MI), dead myocardial tissues are digested by immune cells and replaced by fibrosis, leading to ventricular remodeling and heart failure at the chronic stage. Direct reprogramming of the cardiac fibroblasts (CFs) into induced cardiomyocytes (iCMs) with cardiac transcription factors, including Gata4, Mef2c, and Tbx5 (GMT), may have significant potential for cardiac repair. Sendai virus (SeV) vectors expressing GMT have been reported to reprogram the mouse cardiac fibroblasts into iCMs without any risk of insertional mutagenesis. In vivo reprogramming improved the cardiac function after acute MI in immunodeficient mice. However, it is unknown whether the newly generated iCMs could exist in infarct hearts for a prolonged period and SeV-GMT can improve cardiac function after MI at the chronic stage in immunocompetent mice. Here, we show that SeV vectors efficiently infect CFs in vivo and reprogram them into iCMs, which existed for at least four weeks after MI, in fibroblast-linage tracing mice. Moreover, SeV-GMT improved cardiac function and reduced fibrosis and collagen I expression at 12 weeks after MI in immunocompetent mice. Thus, direct cardiac reprogramming with SeV vectors could be a promising therapy for MI.
AB - Adult hearts have limited regenerative capacity. Hence, after acute myocardial infarction (MI), dead myocardial tissues are digested by immune cells and replaced by fibrosis, leading to ventricular remodeling and heart failure at the chronic stage. Direct reprogramming of the cardiac fibroblasts (CFs) into induced cardiomyocytes (iCMs) with cardiac transcription factors, including Gata4, Mef2c, and Tbx5 (GMT), may have significant potential for cardiac repair. Sendai virus (SeV) vectors expressing GMT have been reported to reprogram the mouse cardiac fibroblasts into iCMs without any risk of insertional mutagenesis. In vivo reprogramming improved the cardiac function after acute MI in immunodeficient mice. However, it is unknown whether the newly generated iCMs could exist in infarct hearts for a prolonged period and SeV-GMT can improve cardiac function after MI at the chronic stage in immunocompetent mice. Here, we show that SeV vectors efficiently infect CFs in vivo and reprogram them into iCMs, which existed for at least four weeks after MI, in fibroblast-linage tracing mice. Moreover, SeV-GMT improved cardiac function and reduced fibrosis and collagen I expression at 12 weeks after MI in immunocompetent mice. Thus, direct cardiac reprogramming with SeV vectors could be a promising therapy for MI.
KW - Cardiac regeneration
KW - Fibroblast
KW - Myocardial infarction
KW - Reprogramming
KW - Sendai virus vector
UR - http://www.scopus.com/inward/record.url?scp=85105486126&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85105486126&partnerID=8YFLogxK
U2 - 10.1016/j.bbrc.2021.04.121
DO - 10.1016/j.bbrc.2021.04.121
M3 - Article
C2 - 33984769
AN - SCOPUS:85105486126
SN - 0006-291X
VL - 560
SP - 87
EP - 92
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
ER -